SmartZyme Biopharma develops novel enzymesfor a variety of medical applications. Based on its proprietary proteinengineering platform, the Provolution, the companydesigns enzymes for improved clinical performanceby engineering them for efficacy and safety. Initially, SmartZyme is focusing on products for diabetes patients, including glucose monitoring test strips and patches. TheProvolution system combines advanced computationalmethods with a random mutagenesis approach, processingmultiple protein characteristics that are required for optimalperformance.
Cumulative Funding Raised Over Time ($)
Employees Over Time
SmartZyme Biopharma Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Dec 4, 2018
www.prnewswire.com
Carnot BioSciences, A Spin Off Of SmartZyme BioPharma, And HemoShear Therapeutics Partner To Develop Protein-Based Therapeutics For Rare Metabolic Diseases
#Partners
Mar 14, 2018
www.prnewswire.com
WallachBeth Capital, LLC Acts as the Sole Placement Agent for SmartZyme's Ongoing Series B-1 Offering
Carnot BioSciences, A Spin Off Of SmartZyme BioPharma, And HemoShear Therapeutics Partner To Develop Protein-Based Therapeutics For Rare Metabolic Diseases
#Partners
Mar 14, 2018
www.prnewswire.com
WallachBeth Capital, LLC Acts as the Sole Placement Agent for SmartZyme's Ongoing Series B-1 Offering